AbbVie
Information

AbbVie

ISIN
US00287Y1091
Ticker
ABBV
ISIN
US00287Y1091
Ticker
ABBV
New Post

Information

large cap stock
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.
Employees
50,000
Industries
Biotechnology & Drugs
Sector
Health Care

Community

Financials

52W Low
$101.81
52W High
$138.15
Market Capitalization
$235.18B
EBITDA
$26.58B
Beta
0.80885

Analyst Ratings

Target Price
$133.14
This security is covered by 25 analysts
Buy
21
Hold
4
Sell
0

Dividends

Activities

Trending